Publications by authors named "Mieke Schutte"

36Publications

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

J Clin Oncol 2016 08 6;34(23):2750-60. Epub 2016 Jun 6.

Marjanka K. Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, and Lizet van der Kolk, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital; Muriel A. Adank, Hanne Meijers, and Quinten Waisfisz, VU University Medical Center, Amsterdam; Antoinette Hollestelle, Mieke Schutte, Maartje Hooning, and Caroline Seynaeve, Erasmus MC Cancer Institute; Ans van den Ouweland, Erasmus University Medical Center, Rotterdam; Rob A.E.M. Tollenaar, Leiden University Medical Center, Leiden, the Netherlands; Irene L. Andrulis and Julia A. Knight, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital; Irene L. Andrulis and Julia A. Knight, University of Toronto, Toronto, Ontario, Canada; Hoda Anton-Culver and Argyrios Ziogas, University of California, Irvine; Peter A. Fasching, David Geffen School of Medicine, University of California, Los Angeles; Esther M. John, Cancer Prevention Institute of California, Fremont; Esther M. John, Alice S. Whittemore, Stanford University School of Medicine, Stanford, CA; Natalia N. Antonenkova, N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus; Antonis C. Antoniou, Manjeet K. Bolla, Andrew Lee, Alison M. Dunning, Paul D.P. Pharoah, Qin Wang, and Douglas F. Easton, University of Cambridge, Cambridge; Angela Cox and Simon S. Cross, University of Sheffield, Sheffield; Olivia Fletcher, Michael Jones, and Anthony Swerdlow, The Institute of Cancer Research; Julian Peto, London School of Hygiene and Tropical Medicine; Elinor J. Sawyer, King's College London, London; Jonine Figueroa, University of Edinburgh Medical School, Edinburgh; Ian Tomlinson, University of Oxford, Oxford, United Kingdom; Volker Arndt, Hiltrud Brauch, Hermann Brenner, Barbara Burwinkel, Jenny Chang-Claude, Anja Rudolph, Harold Surowy, German Cancer Research Center; Barbara Burwinkel and Harald Surowy, University of Heidelberg, Heidelberg; Natalia V. Bogdanova, Peter Hillemanns, Tjoung-Won Park-Simon, and Thilo

View Article and Find Full Text PDF
August 2016

Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice.

Breast Cancer Res Treat 2014 Nov 30;148(1):19-31. Epub 2014 Sep 30.

Department of Medical Oncology and Cancer Genomics Centre, Erasmus University Medical Center - Daniel den Hoed Cancer Center, 3000 CA, Rotterdam, The Netherlands,

View Article and Find Full Text PDF
November 2014

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

Breast Cancer Res Treat 2013 Feb 22;138(1):47-57. Epub 2013 Jan 22.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
February 2013

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.

Breast Cancer Res Treat 2012 Nov 29;136(2):365-77. Epub 2012 Sep 29.

Laboratory for Experimental Surgical Oncology, Section Surgical Oncology, Daniel den Hoed Cancer Center, Erasmus University Medical Centre, PO Box 1738, 3000 DR, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
November 2012

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Breast Cancer Res Treat 2011 May 9;127(1):33-41. Epub 2010 Apr 9.

Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Erasmus MC, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article and Find Full Text PDF
May 2011

Discovering moderate-risk breast cancer susceptibility genes.

Curr Opin Genet Dev 2010 Jun 24;20(3):268-76. Epub 2010 Mar 24.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
June 2010

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.

Breast Cancer Res Treat 2010 Dec 27;124(3):635-41. Epub 2010 Feb 27.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Centre, Be414, Erasmus MC, CA, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
December 2010

Association of rare MSH6 variants with familial breast cancer.

Breast Cancer Res Treat 2010 Sep 19;123(2):315-20. Epub 2009 Nov 19.

Department of Medical Oncology, Josephine Nefkens Institute Be414, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
September 2010

Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade.

J Biol Chem 2009 Dec;284(51):35308-13

Hubrecht Institute-KNAW and University Medical Centre Utrecht, Uppsalalaan 8, 3584CT Utrecht.

View Article and Find Full Text PDF
December 2009

Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.

Breast Cancer Res Treat 2010 Jul 18;122(1):125-33. Epub 2009 Sep 18.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article and Find Full Text PDF
July 2010

Low-risk susceptibility alleles in 40 human breast cancer cell lines.

BMC Cancer 2009 Jul 16;9:236. Epub 2009 Jul 16.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article and Find Full Text PDF
July 2009

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

Authors:
Shahana Ahmed Gilles Thomas Maya Ghoussaini Catherine S Healey Manjeet K Humphreys Radka Platte Jonathan Morrison Melanie Maranian Karen A Pooley Robert Luben Diana Eccles D Gareth Evans Olivia Fletcher Nichola Johnson Isabel dos Santos Silva Julian Peto Michael R Stratton Nazneen Rahman Kevin Jacobs Ross Prentice Garnet L Anderson Aleksandar Rajkovic J David Curb Regina G Ziegler Christine D Berg Saundra S Buys Catherine A McCarty Heather Spencer Feigelson Eugenia E Calle Michael J Thun W Ryan Diver Stig Bojesen Børge G Nordestgaard Henrik Flyger Thilo Dörk Peter Schürmann Peter Hillemanns Johann H Karstens Natalia V Bogdanova Natalia N Antonenkova Iosif V Zalutsky Marina Bermisheva Sardana Fedorova Elza Khusnutdinova Daehee Kang Keun-Young Yoo Dong Young Noh Sei-Hyun Ahn Peter Devilee Christi J van Asperen R A E M Tollenaar Caroline Seynaeve Montserrat Garcia-Closas Jolanta Lissowska Louise Brinton Beata Peplonska Heli Nevanlinna Tuomas Heikkinen Kristiina Aittomäki Carl Blomqvist John L Hopper Melissa C Southey Letitia Smith Amanda B Spurdle Marjanka K Schmidt Annegien Broeks Richard R van Hien Sten Cornelissen Roger L Milne Gloria Ribas Anna González-Neira Javier Benitez Rita K Schmutzler Barbara Burwinkel Claus R Bartram Alfons Meindl Hiltrud Brauch Christina Justenhoven Ute Hamann Jenny Chang-Claude Rebecca Hein Shan Wang-Gohrke Annika Lindblom Sara Margolin Arto Mannermaa Veli-Matti Kosma Vesa Kataja Janet E Olson Xianshu Wang Zachary Fredericksen Graham G Giles Gianluca Severi Laura Baglietto Dallas R English Susan E Hankinson David G Cox Peter Kraft Lars J Vatten Kristian Hveem Merethe Kumle Alice Sigurdson Michele Doody Parveen Bhatti Bruce H Alexander Maartje J Hooning Ans M W van den Ouweland Rogier A Oldenburg Mieke Schutte Per Hall Kamila Czene Jianjun Liu Yuqing Li Angela Cox Graeme Elliott Ian Brock Malcolm W R Reed Chen-Yang Shen Jyh-Cherng Yu Giu-Cheng Hsu Shou-Tung Chen Hoda Anton-Culver Argyrios Ziogas Irene L Andrulis Julia A Knight Jonathan Beesley Ellen L Goode Fergus Couch Georgia Chenevix-Trench Robert N Hoover Bruce A J Ponder David J Hunter Paul D P Pharoah Alison M Dunning Stephen J Chanock Douglas F Easton

Nat Genet 2009 May 29;41(5):585-90. Epub 2009 Mar 29.

Department of Oncology, University of Cambridge, UK.

View Article and Find Full Text PDF
May 2009

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

J Natl Cancer Inst 2009 Jan 30;101(1):61-6. Epub 2008 Dec 30.

Department of Medical Oncology, Josephine Nefkens Institute, Cancer Genomics Centre, Rotterdam, the Netherlands.

View Article and Find Full Text PDF
January 2009

CHEK2 1100delC and male breast cancer in the Netherlands.

Breast Cancer Res Treat 2009 Jul 31;116(2):397-400. Epub 2008 Aug 31.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, CA, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
July 2009

Exon expression arrays as a tool to identify new cancer genes.

PLoS One 2007 Aug 20;3(8):e3007. Epub 2007 Aug 20.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
August 2007

CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.

Clin Cancer Res 2008 Aug;14(15):4989-94

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article and Find Full Text PDF
August 2008

Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.

Breast Cancer Res Treat 2009 Jan 24;113(2):285-91. Epub 2008 Feb 24.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
January 2009

Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.

Mol Cancer Res 2007 Feb;5(2):195-201

Department of Medical Oncology, Josephine Nefkens Institute Be414, Erasmus MC, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands.

View Article and Find Full Text PDF
February 2007

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

Breast Cancer Res Treat 2007 Aug 2;104(2):153-7. Epub 2006 Nov 2.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article and Find Full Text PDF
August 2007

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.

Breast Cancer Res Treat 2006 Sep 16;99(1):97-101. Epub 2006 Mar 16.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
September 2006

BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.

Cancer Res 2006 Jan;66(1):41-5

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
January 2006

Representational difference analysis as a tool in the search for new tumor suppressor genes.

Methods Mol Med 2005 ;103:143-59

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands.

View Article and Find Full Text PDF
July 2005

NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.

Oncogene 2004 Nov;23(53):8681-7

Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
November 2004

Mutation rate of MAP2K4/MKK4 in breast carcinoma.

Hum Mutat 2002 Jan;19(1):81

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article and Find Full Text PDF
January 2002